Spotlight Therapeutics' cell|specific in vivo gene editing platform ...

Spotlight Therapeutics Venture Capital and Private Equity Financings

Established in mid-2018, Spotlight Therapeutics is a privately held biotechnology company advancing a pipeline of cell-targeted in vivo CRISPR gene editing ...

Spotlight Therapeutics Closes $30 Million Series A to Advance ...

Spotlight Therapeutics, a Calif.-based biotech company focused on in vivo CRISPR (clusters of regularly interspaced short palindromic repeats) ...

Spotlight Therapeutics Raises $36.5M in Series B Funding - FinSMEs

Spotlight Therapeutics, Inc., a Hayward, California-based biotechnology company applying new insights to develop cell-targeted in vivo ...

Introduction — Spotlight Therapeutics

A fundamental challenge of CRISPR-based therapeutics is to safely deliver gene editing molecules to the appropriate cells in vivo. Spotlight is addressing ...

Gene Editing Startups Cut Fine Therapeutic Figures

Spotlight's Targeted Active Gene Editing (TAGE) platform, which delivers CRISPR molecules to selected cell types in vivo, is designed to ...

Spotlight Raises $30 Million to Advance Pipeline of Non-Viral ...

Spotlight Therapeutics said it closed a $30 million series A financing round to develop non-viral gene editing therapeutics for direct in vivo ...

CRISPR Technology Turns 10, Rises to New Challenges: Ever since ...

Spotlight Therapeutics is addressing multiple limitations of the current in vivo delivery systems by developing engineered ribonucleoproteins with its Targeted ...

Careers - Spotlight Therapeutics

Taking a biologics approach, our creative, mission-driven team has developed a proprietary platform of Targeted Active Gene Editors (TAGE), engineered cell- ...

Spotlight Therapeutics Closes $30M Series A Led by GV to Advance ...

Spotlight's proprietary technology platform develops programmable CRISPR ribonucleoproteins (RNPs) optimized for in vivo cell-targeted delivery.

Jobs at Spotlight Therapeutics | Foothill Ventures

With a therapeutic focus centered on oncology, our engineered nucleases edit the genes in targeted disease organs thereby inactivating or altering the gene ...

Ex Vivo Cell-Based CRISPR/Cas9 Genome Editing for Therapeutic ...

In this review, we highlight the ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications. In these studies, CRISPR/Cas9 tools were used to ...

Gene Editing Gets Ready for the Spotlight | BCG

Cell and gene therapies are demonstrating their transformative potential, with multiple treatments receiving regulatory approval and many more ...

ElevateBio: Cell and Gene Therapy Innovation Right From The Start

Our proprietary technologies – including gene editing, cell therapy enabling technologies, RNA engineering, and viral and non-viral delivery platforms – power ...

Spotlight Therapeutics - Company Profile - Tracxn

Developer of cancer therapeutics using gene editing. It has a properitory platform TAGE (Targeted Active Gene Editors) delivers CRISPR ...

Presentations and posters - Spotlight Therapeutics

Spotlight Therapeutics is developing RNP-based biologics to enable gene editing of selected cell types in vivo. This new class of modular RNPs, called TAGE ( ...

Cell and Gene Therapy - Lonza Bioscience

Cell and gene therapy is a rapidly developing field. It promises significant long-term health benefits to people suffering from a wide range of diseases, from ...

Michael Severino on In Vivo Gene Editing With RNA Gene Writers

The cell and gene therapy sectors are growing exponentially, with new players emerging daily and much progress being made both in and out of the ...

SCGE at ASGCT 2024 - Somatic Cell Gene Editing

Thursday May 9th · 2084: Hemophilia gene therapy follow up, factor 8 and 9, dose-response, efficacy, durability · 2078: How Confident Are You?

Cell and Gene Therapy Insights - BioInsights

Overcoming the senescence barrier in stem cell expansion · Revolutionizing the treatment of cancer with allogeneic CAR-T cell therapy · Enhancing ...

About - Intellia Therapeutics

Gene editing uses systems to make the DNA change inside the cell. These cells can be edited in the body (in vivo) or outside the body (ex vivo) ...